Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Disease × Thoracic × Clear all

Phase

Phase NA 36 Phase 3 5 Phase 1/2 3 Phase 2 2 Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 3 Genitourinary 3 Gastrointestinal 3 CNS 3 Gynecologic 2 Thoracic 1 Sarcoma 1 Other 1 NET 1 Lymphoid 1 Endocrine 1 Dermatologic 1 Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 1096 Lung Neoplasms 501 Colorectal Neoplasms 239 Neoplasms 231 Breast Neoplasms 229 Small Cell Lung Carcinoma 204 Ovarian Neoplasms 204 Melanoma 201 Pancreatic Neoplasms 165 Squamous Cell Carcinoma of Head and Neck 147 Neoplasm Metastasis 146 Carcinoma, Renal Cell 141 Stomach Neoplasms 137 Triple Negative Breast Neoplasms 110 Head and Neck Neoplasms 108 Esophageal Neoplasms 99 Prostatic Neoplasms 93 Urinary Bladder Neoplasms 92 Colonic Neoplasms 87 Uterine Cervical Neoplasms 81 Endometrial Neoplasms 78 Mesothelioma 76 Mesothelioma, Malignant 75 Carcinoma, Hepatocellular 63 Sarcoma 61 Kidney Neoplasms 59 Carcinoma, Transitional Cell 56 Carcinoma, Ovarian Epithelial 46 Adenocarcinoma of Lung 44 Rectal Neoplasms 40

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04855929 2024-11-08

ANV419-001

Anaveon AG

Phase 1 Completed

Disease, Lung Neoplasms, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡